Dividend Aristocrat Johnson & Johnson (JNJ) reported Q2-21 earnings per share of $2.48 beating estimates by $0.19. Also, the revenues of $23.31B (+27.1% Y/Y) were above expectations, beating estimates by $770M.
The company expects revenues between $92.5B-$93.3B vs. $92.55B consensus for the full year. Adjusted earnings per share have been increased to $9.50-$9.60 from prior a guidance of $9.42-$9.57 vs. $9.55 consensus. Including COVID-19 vaccine revenue, 2021 growth is estimated at 13.5-14.5% YoY.
Johnson & Johnson ended the trading day up 0.62% or $1.04 with a share price of $169.49. The current annual dividend per share of $4.24, results in a dividend yield of 2.54%. Johnson & Johnson has 59 years of consecutive dividend increases, which makes it a dividend aristocrat and dividend king.